Pfizer Inc (PFE)
25.38
+0.12
(+0.48%)
USD |
NYSE |
Apr 26, 16:00
25.44
+0.06
(+0.24%)
After-Hours: 20:00
Pfizer Research and Development Expense (Annual): 10.68B for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 10.68B |
| December 31, 2022 | 11.43B |
| December 31, 2021 | 10.36B |
| December 31, 2020 | 9.393B |
| December 31, 2019 | 8.385B |
| December 31, 2018 | 7.76B |
| December 31, 2017 | 7.683B |
| December 31, 2016 | 7.892B |
| December 31, 2015 | 7.69B |
| December 31, 2014 | 8.393B |
| December 31, 2013 | 6.678B |
| December 31, 2012 | 7.482B |
| December 31, 2011 | 8.681B |
| December 31, 2010 | 9.483B |
| Date | Value |
|---|---|
| December 31, 2009 | 7.845B |
| December 31, 2008 | 8.578B |
| December 31, 2007 | 8.089B |
| December 31, 2006 | 7.599B |
| December 31, 2005 | 7.256B |
| December 31, 2004 | 7.513B |
| December 31, 2003 | 7.487B |
| December 31, 2002 | 5.208B |
| December 31, 2001 | 4.776B |
| December 31, 2000 | 4.435B |
| December 31, 1999 | 4.036B |
| December 31, 1998 | 3.305B |
| December 31, 1997 | 1.805B |
| December 31, 1996 | 1.567B |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
8.385B
Minimum
2019
11.43B
Maximum
2022
10.05B
Average
10.36B
Median
2021
Research and Development Expense (Annual) Benchmarks
| Amgen Inc | 4.784B |
| Gilead Sciences Inc | 5.718B |
| Johnson & Johnson | 15.08B |
| Viking Therapeutics Inc | 63.81M |
| Moderna Inc | 4.845B |